Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 291

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 16G
Chunk 291
---
 (vi) certain non-public issuances of securities. In addition,        
        under the Companies Law, a merger requires approval of the shareholders of each of the merging companies. We are not required, however,    
                          to seek shareholder approval for any of the following events described in the Nasdaq Listing Rules:                      
---------------------------------------------------------------------------------------------------------------------------------------------------

◾   certain issuances of shares in excess of 20% of the outstanding shares of the Company;
------------------------------------------------------------------------------------------

◾   an issuance that will result in a change of control of our company; and
---------------------------------------------------------------------------

◾   adoption of, or material changes to, our equity compensation plans.
-----------------------------------------------------------------------